| NCT ID | NCT00575081 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt University Medical Center |
| Condition | Parkinson's Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2006-08 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2006-08 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease, Dystonia, Essential Tremor, and OCD, but now includes data acquired during all stereotactic brain procedures.
Eligibility Criteria
Inclusion Criteria: * All patients who are recommended for Stereotactic Brain procedures * Any patient who has agreed to undergo a Stereotactic Brain procedure * Patients age under 6 -90 years old Exclusion Criteria: * Patients who fail recommendation for Stereotactic Brain procedures * Patients not consented for Stereotactic Brain procedures * Patients outside the age range of 6 -90 years old * Patients or legal guardians not able to provide informed consent
Contact & Investigator
Darioq j Englot, MD, Ph.D.
PRINCIPAL INVESTIGATOR
Vanderbilt University, Dept. Neurosurgery
Frequently Asked Questions
Who can join the NCT00575081 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 90 Years, studying Parkinson's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00575081 currently recruiting?
Yes, NCT00575081 is actively recruiting participants. Contact the research team at dario.englot@vumc.org for enrollment information.
Where is the NCT00575081 trial being conducted?
This trial is being conducted at Nashville, United States.
Who is sponsoring the NCT00575081 clinical trial?
NCT00575081 is sponsored by Vanderbilt University Medical Center. The principal investigator is Darioq j Englot, MD, Ph.D. at Vanderbilt University, Dept. Neurosurgery. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.